242 related articles for article (PubMed ID: 24319102)
21. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
[TBL] [Abstract][Full Text] [Related]
22. Peripheral blood sCD3⁻ CD4⁺ T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma.
Singh A; Schabath R; Ratei R; Stroux A; Klemke CD; Nebe T; Flörcken A; van Lessen A; Anagnostopoulos I; Dörken B; Ludwig WD; Pezzutto A; Westermann J
Hematol Oncol; 2014 Mar; 32(1):16-21. PubMed ID: 23798351
[TBL] [Abstract][Full Text] [Related]
23. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
24. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
Lima M; Almeida J; dos Anjos Teixeira M; Queiros ML; Santos AH; Fonseca S; Balanzategui A; Justica B; Orfao A
Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
[TBL] [Abstract][Full Text] [Related]
25. CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement.
Introcaso CE; Kim EJ; Gardner J; Junkins-Hopkins JM; Vittorio CC; Rook AH
Arch Dermatol; 2008 Aug; 144(8):1027-9. PubMed ID: 18711076
[TBL] [Abstract][Full Text] [Related]
26. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
[TBL] [Abstract][Full Text] [Related]
27. CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas.
Laetsch B; Häffner AC; Döbbeling U; Seifert B; Ludwig E; Burg G; Dummer R
J Invest Dermatol; 2000 Jan; 114(1):107-11. PubMed ID: 10620124
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric identification of immunophenotypically aberrant T-cell clusters on skin shave biopsy specimens from patients with mycosis fungoides.
Horna P; Kurant D; Sokol L; Sotomayor EM; Moscinski L; Glass LF
Am J Clin Pathol; 2015 Jun; 143(6):785-96. PubMed ID: 25972320
[TBL] [Abstract][Full Text] [Related]
29. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
Lyapichev KA; Bah I; Huen A; Duvic M; Routbort MJ; Wang W; Jorgensen JL; Medeiros LJ; Vega F; Craig FE; Wang SA
Cytometry B Clin Cytom; 2021 Mar; 100(2):183-191. PubMed ID: 32667737
[TBL] [Abstract][Full Text] [Related]
30. Stage-dependent expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive peripheral blood T-lymphocytes in cutaneous T-cell lymphoma.
Jakob T; Neuber K; Altenhoff J; Kowalzick L; Ring J
Acta Derm Venereol; 1996 Jan; 76(1):34-6. PubMed ID: 8721488
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma.
Nagatani T; Miyazawa M; Matsuzaki T; Iemoto G; Kim ST; Baba N; Miyamoto H; Nakajima H
Semin Dermatol; 1994 Sep; 13(3):216-22. PubMed ID: 7986691
[TBL] [Abstract][Full Text] [Related]
32. High clinical response rate of Sezary syndrome to immunomodulatory therapies: prognostic markers of response.
Raphael BA; Shin DB; Suchin KR; Morrissey KA; Vittorio CC; Kim EJ; Gardner JM; Evans KG; Introcaso CE; Samimi SS; Gelfand JM; Rook AH
Arch Dermatol; 2011 Dec; 147(12):1410-5. PubMed ID: 21844430
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue.
Wang S; Li N; Heald P; Fisk JM; Fadare O; Howe JG; McNiff JM; Smith BR
Am J Clin Pathol; 2004 Nov; 122(5):774-82. PubMed ID: 15491974
[TBL] [Abstract][Full Text] [Related]
35. Immunophenotypic stability of Sézary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.
Vaughan J; Harrington AM; Hari PN; Kroft SH; Olteanu H
Am J Clin Pathol; 2012 Mar; 137(3):403-11. PubMed ID: 22338052
[TBL] [Abstract][Full Text] [Related]
36. Flow Cytometric Analysis of T, B, and NK Cells Antigens in Patients with Mycosis Fungoides.
Yazıcı S; Bülbül Başkan E; Budak F; Oral B; Adim ŞB; Ceylan Kalin Z; Özkaya G; Aydoğan K; Saricaoğlu H; Tunali Ş
J Immunol Res; 2015; 2015():856340. PubMed ID: 26788525
[TBL] [Abstract][Full Text] [Related]
37. Sézary cell counts in erythrodermic cutaneous T-cell lymphoma: implications for prognosis and staging.
Vonderheid EC; Pena J; Nowell P
Leuk Lymphoma; 2006 Sep; 47(9):1841-56. PubMed ID: 17064997
[TBL] [Abstract][Full Text] [Related]
38. Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma.
Weng WK; Armstrong R; Arai S; Desmarais C; Hoppe R; Kim YH
Sci Transl Med; 2013 Dec; 5(214):214ra171. PubMed ID: 24307695
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
Klemke CD; Brade J; Weckesser S; Sachse MM; Booken N; Neumaier M; Goerdt S; Nebe TC
Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
[TBL] [Abstract][Full Text] [Related]
40. CD4
Vonderheid EC; Hou JS
Leuk Lymphoma; 2018 Feb; 59(2):330-339. PubMed ID: 28595473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
